These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


113 related items for PubMed ID: 3658014

  • 1. [The prognostic significance of alkaline and acid phosphatase levels in the hormonal treatment of patients with prostatic carcinoma].
    Mulders PF, Debruyne FM.
    Ned Tijdschr Geneeskd; 1987 Aug 08; 131(32):1399-402. PubMed ID: 3658014
    [No Abstract] [Full Text] [Related]

  • 2. Serum markers as a predictor of response duration and patient survival after hormonal therapy for metastatic carcinoma of the prostate.
    Smith JA, Lange PH, Janknegt RA, Abbou CC, deGery A.
    J Urol; 1997 Apr 08; 157(4):1329-34. PubMed ID: 9120932
    [Abstract] [Full Text] [Related]

  • 3. The treatment of advanced prostatic carcinoma with medroxyprogesterone.
    Rafla S, Johnson R.
    Curr Ther Res Clin Exp; 1974 Apr 08; 16(4):261-7. PubMed ID: 4208339
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clinical aspects of prostatic carcinoma.
    Foo KT, Tan EC, Tung KH, Lee YS.
    Singapore Med J; 1982 Oct 08; 23(5):269-72. PubMed ID: 7157007
    [No Abstract] [Full Text] [Related]

  • 10. [Contribution on the clinical aspects of prostatic carcinoma].
    Sladczyk E.
    Z Arztl Fortbild (Jena); 1967 Jul 01; 61(13):657-60. PubMed ID: 5598256
    [No Abstract] [Full Text] [Related]

  • 11. [Treatment of advanced metastasizing carcinoma of the prostate with estracyt (author's transl)].
    Rambausek M, Lutherer S, Terhorst B.
    Urologe A; 1981 Jul 01; 20(4):223-7. PubMed ID: 7196632
    [Abstract] [Full Text] [Related]

  • 12. [Enzymological study of prostatic cancer. VI. Serum acid phosphatase level and prognosis of patients with prostatic carcinoma (author's transl)].
    Ishibe T.
    Nihon Hinyokika Gakkai Zasshi; 1974 Feb 01; 65(2):102-7. PubMed ID: 4471809
    [No Abstract] [Full Text] [Related]

  • 13. [Prognosis and treatment of prostatic carcinoma].
    Klug W.
    Zentralbl Chir; 1968 Mar 09; 93(10):362-6. PubMed ID: 5674208
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Enzymological study of prostatic cancer. II. Serum lactic dehydrogenase, alkaline phosphatase, leucine aminopeptidase, total acid phosphatase, prostatic acid phosphatase activity and lactic dehydrogenase isoenzymes in prostatic cancer, with special reference to relation with stage and histological malignancy].
    Ishibe T, Nihira H, Mori K.
    Hinyokika Kiyo; 1969 Apr 09; 15(4):254-65. PubMed ID: 5817349
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Androgen level variations, clinical response to LHRH agonists and changes in the quality of life subscales in metastatic prostate cancer--speculations about possible role of the monoamine system.
    Popov I, Jelić S, Radosavljević D, Nikolić-Tomasević Z.
    Neoplasma; 1997 Apr 09; 44(5):308-13. PubMed ID: 9473791
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Value of acid phosphatase in screening for carcinoma in patients with prostatism in Nigeria.
    Anyanwu SN.
    East Afr Med J; 1996 Jul 09; 73(7):457-8. PubMed ID: 8918008
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.